CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Retained Earnings
Balance at Dec. 31, 2022	$ 1,910,700	$ 556	$ 1,547,266	$ (34,394)	$ 397,272
Beginning Balance (in shares) at Dec. 31, 2022		55,557,698
Net income	15,337				15,337
Exercise of stock options and vesting of stock units	29	$ 1	28
Exercise of stock options and vesting of stock units (in shares)		140,210
Tax withholding on vesting of restricted stock units	(9,593)	$ (1)	(9,592)
Tax withholding on vesting of restricted stock units (in shares)		(53,607)
Stock-based compensation expense	7,254		7,254
Balance at Mar. 31, 2023	1,926,714	$ 556	1,544,956	(31,407)	412,609
Ending Balance (in shares), as restated at Mar. 31, 2023		55,644,301
Translation adjustment, as restated	2,987			2,987
Balance at Dec. 31, 2023	1,964,845	$ 558	1,569,227	(37,808)	432,868
Beginning Balance (in shares) at Dec. 31, 2023		55,766,078
Net income	3,296				3,296
Exercise of stock options and vesting of stock units	945	$ 1	944
Exercise of stock options and vesting of stock units (in shares)		111,921
Tax withholding on vesting of restricted stock units	(7,622)		(7,622)
Tax withholding on vesting of restricted stock units (in shares)		(39,451)
Issuance of common stock pursuant to contingent consideration earnout payment	541		541
Issuance of common stock pursuant to contingent consideration earnout payment (in shares)		$ 2,770
Conversion of debt	(55)		(55)
Stock-based compensation expense	8,776		8,776
Balance at Mar. 31, 2024	1,965,592	$ 559	$ 1,571,811	(42,942)	$ 436,164
Ending Balance (in shares), as restated at Mar. 31, 2024		55,841,318
Translation adjustment, as restated	$ (5,134)			$ (5,134)